Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) — Capital Reinvestment Ratio
Shanghai Allist Pharmaceuticals Co. Ltd. A (688578) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥670.83 Million) in capital expenditures (CN¥63.68 Million). See Shanghai Allist Pharmaceuticals Co. Ltd. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shanghai Allist Pharmaceuticals Co. Ltd. A Capital Reinvestment Ratio (2017–2025)
This chart tracks Shanghai Allist Pharmaceuticals Co. Ltd. A's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A (2017–2025)
Year-by-year Capital Reinvestment Ratio for Shanghai Allist Pharmaceuticals Co. Ltd. A from 2017 to 2025. For live market cap and broader valuation context, see Shanghai Allist Pharmaceuticals Co. Ltd. market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.08x | CN¥2.32 Billion | CN¥186.00 Million | ▼ -53.6% |
| 2024 | 0.17x | CN¥1.57 Billion | CN¥270.22 Million | ▲ +71.5% |
| 2023 | 0.10x | CN¥674.65 Million | CN¥67.88 Million | ▼ -93.6% |
| 2022 | 1.57x | CN¥91.63 Million | CN¥143.83 Million | ▼ -76.1% |
| 2021 | 6.56x | CN¥29.29 Million | CN¥192.25 Million | ▲ +4656.5% |
| 2017 | 0.14x | CN¥10.11 Million | CN¥1.40 Million | — |